A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms SFA ISR
- 30 Mar 2017 Planned End Date changed from 1 Dec 2021 to 1 Feb 2021.
- 16 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017.
- 16 Jan 2017 Status changed from recruiting to active, no longer recruiting.